4Engineer L, Bhol KC, Ahmed AR. Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris. J Am Acad Dermatol, 2000, 43(6) :1049 - 1057.
5Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol, 2000, 42 ( 3 ) :422 - 427.
7Kanwar AJ, Kaur S, Thami GP. Long-term efficacy of dexamethasonecyclophosphamide pulse therapy in pemphigus. Dermatology, 2002,204(3) :228 -231.
8Brodsky RA, Petri M, Smith BD, et al. Immunoablative highdose cyclophosphamide without stem-cell rescue for refractor, severe autoimmune disease. Ann Intern Med, 1998, 129(12) :1031 -1035.
9Hayag MV, Cohen JA, Kerdel FA. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vnlgaris. J Am Acad Dermatol, 2000, 43(6) :1065 - 1069.
10Takamori K. Recent advances in the treatment of autoimmune bullous diseases. J Dermatol, 2001, 28 ( 11 ) :654 - 657.
